EYEPOINT PHARMACEUTICALS INC (EYPT) Top Institutional Shareholders
EYEPOINT PHARMACEUTICALS INC (EYPT) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $1.14B in EYPT holdings during the latest filing period.
Suvretta Capital Management, Llc is currently the largest disclosed institutional shareholder of EYPT tracked by InsiderSet, reporting ownership valued at approximately $106.94M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $109.10M, representing an estimated gain of +2.02% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 58% of the total disclosed EYPT value among the investors covered in this analysis. Major shareholders include Suvretta Capital Management, Llc, Cormorant Asset Management, Lp, Blackrock, Inc., and several other long-term asset managers with concentrated positions in EYEPOINT PHARMACEUTICALS INC (EYPT).
This page ranks the largest institutional EYPT shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
183
Total Reported Value
$1.14B
Largest Holder
Suvretta Capital Management, Llc
Largest Position
$106.94M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
189
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Suvretta Capital Management, Llc | 2.90% | 8,296,375 | $106,940,274 | $109,097,331 | +$2,157,057 | +2.02% | |
| Cormorant Asset Management, Lp | 5.37% | 8,265,000 | $106,535,850 | $108,684,750 | +$2,148,900 | +2.02% | |
| Blackrock, Inc. | 0.00% | 7,177,337 | $92,515,874 | $94,381,982 | +$1,866,108 | +2.02% | |
| Federated Hermes, Inc. | 0.12% | 5,669,589 | $73,081,003 | $74,555,095 | +$1,474,092 | +2.02% | |
| Franklin Resources Inc | 0.02% | 5,048,598 | $65,076,424 | $66,389,064 | +$1,312,640 | +2.02% | |
| Janus Henderson Group Plc | 0.02% | 3,601,168 | $46,419,056 | $47,355,359 | +$936,303 | +2.02% | |
| Vanguard Capital Management Llc | 0.00% | 3,559,569 | $45,882,844 | $46,808,332 | +$925,488 | +2.02% | |
| Adage Capital Partners Gp, L.L.C. | 0.07% | 3,300,000 | $42,537,000 | $43,395,000 | +$858,000 | +2.02% | |
| Paradigm Biocapital Advisors Lp | 0.83% | 3,142,437 | $40,506,013 | $41,323,047 | +$817,034 | +2.02% | |
| Commodore Capital Lp | 2.11% | 2,825,000 | $36,414,250 | $37,148,750 | +$734,500 | +2.02% | |
| State Street Corp | 0.00% | 2,097,202 | $27,032,934 | $27,578,206 | +$545,272 | +2.02% | |
| Geode Capital Management, Llc | 0.00% | 1,983,665 | $25,573,730 | $26,085,195 | +$511,465 | +2.00% | |
| Citadel Advisors Llc | 0.02% | 1,905,875 | $24,566,729 | $25,062,256 | +$495,527 | +2.02% | |
| Aberdeen Group Plc | 0.04% | 1,738,378 | $22,407,692 | $22,859,671 | +$451,979 | +2.02% | |
| Balyasny Asset Management L.P. | 0.04% | 1,438,737 | $18,545,320 | $18,919,392 | +$374,072 | +2.02% | |
| Parkman Healthcare Partners Llc | 1.81% | 1,354,800 | $17,463,372 | $17,815,620 | +$352,248 | +2.02% | |
| Eventide Asset Management, Llc | 0.27% | 1,245,583 | $16,055,565 | $16,379,416 | +$323,851 | +2.02% | |
| Morgan Stanley | 0.00% | 1,096,109 | $14,128,844 | $14,413,833 | +$284,989 | +2.02% | |
| Essex Woodlands Management, Inc. | 5.58% | 1,084,857 | $13,983,807 | $14,265,870 | +$282,063 | +2.02% | |
| Orbimed Advisors Llc | 0.30% | 1,069,147 | $13,781,305 | $14,059,283 | +$277,978 | +2.02% | |
| 5Am Venture Management, Llc | 3.76% | 1,050,000 | $13,534,500 | $13,807,500 | +$273,000 | +2.02% | |
| Rosalind Advisors, Inc. | 5.48% | 1,036,737 | $13,363,540 | $13,633,092 | +$269,552 | +2.02% | |
| Blue Owl Capital Holdings Lp | 3.16% | 912,594 | $11,763,337 | $12,000,611 | +$237,274 | +2.02% | |
| Hsbc Holdings Plc | 0.01% | 833,455 | $10,743,235 | $10,959,933 | +$216,698 | +2.02% | |
| Stempoint Capital Lp | 2.04% | 810,764 | $10,450,748 | $10,661,547 | +$210,799 | +2.02% | |
| Patient Square Capital Lp | 1.82% | 795,000 | $10,247,550 | $10,454,250 | +$206,700 | +2.02% | |
| Vanguard Portfolio Management Llc | 0.00% | 793,870 | $10,232,984 | $10,439,391 | +$206,407 | +2.02% | |
| Artia Global Partners Lp | 2.23% | 767,098 | $9,887,893 | $10,087,339 | +$199,446 | +2.02% | |
| Sio Capital Management, Llc | 1.34% | 721,785 | $9,303,809 | $9,491,473 | +$187,664 | +2.02% | |
| Goldman Sachs Group Inc | 0.00% | 699,706 | $9,019,210 | $9,201,134 | +$181,924 | +2.02% | |
| Northern Trust Corp | 0.00% | 676,812 | $8,724,107 | $8,900,078 | +$175,971 | +2.02% | |
| Candriam S.C.A. | 0.05% | 674,395 | $8,692,952 | $8,868,294 | +$175,342 | +2.02% | |
| Charles Schwab Investment Management Inc | 0.00% | 640,123 | $8,251,185 | $8,417,617 | +$166,432 | +2.02% | |
| Alyeska Investment Group, L.P. | 0.02% | 509,403 | $6,566,205 | $6,698,649 | +$132,444 | +2.02% | |
| Vanguard Fiduciary Trust Co | 0.00% | 504,472 | $6,502,644 | $6,633,807 | +$131,163 | +2.02% | |
| Millennium Management Llc | 0.00% | 475,190 | $6,125,199 | $6,248,749 | +$123,550 | +2.02% | |
| Exoduspoint Capital Management, Lp | 0.06% | 458,102 | $5,904,935 | $6,024,041 | +$119,106 | +2.02% | |
| Two Sigma Investments, Lp | 0.00% | 430,315 | $5,546,760 | $5,658,642 | +$111,882 | +2.02% | |
| Ameriprise Financial Inc | 0.00% | 423,262 | $5,455,849 | $5,565,895 | +$110,046 | +2.02% | |
| Dimensional Fund Advisors Lp | 0.00% | 401,121 | $5,164,577 | $5,274,741 | +$110,164 | +2.13% | |
| Bank Of America Corp | 0.00% | 383,443 | $4,942,579 | $5,042,275 | +$99,696 | +2.02% | |
| Myda Advisors Llc | 1.00% | 330,000 | $4,253,700 | $4,339,500 | +$85,800 | +2.02% | |
| Simplify Asset Management Inc. | 0.06% | 326,142 | $4,203,970 | $4,288,767 | +$84,797 | +2.02% | |
| Bleichroeder Lp | 0.71% | 316,515 | $4,079,878 | $4,162,172 | +$82,294 | +2.02% | |
| Walleye Capital Llc | 0.02% | 300,184 | $3,869,372 | $3,947,420 | +$78,048 | +2.02% | |
| Granahan Investment Management, Llc | 0.19% | 297,108 | $3,829,722 | $3,906,970 | +$77,248 | +2.02% | |
| Nuveen, Llc | 0.00% | 260,276 | $3,354,957 | $3,422,629 | +$67,672 | +2.02% | |
| Wellington Management Group Llp | 0.00% | 258,942 | $3,337,762 | $3,405,087 | +$67,325 | +2.02% | |
| Rock Springs Capital Management Lp | 0.20% | 258,739 | $3,335,146 | $3,402,418 | +$67,272 | +2.02% | |
| Bank Of New York Mellon Corp | 0.00% | 255,381 | $3,291,857 | $3,358,260 | +$66,403 | +2.02% |
Frequently asked questions about EYPT
Who owns the most EYPT stock?
The largest holders of EYPT are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for EYEPOINT PHARMACEUTICALS INC (EYPT).
Is EYPT widely held by superinvestors?
Many widely followed stocks like EYPT appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly EYPT is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.